
FSI Régions backs Axonal OBO
FSI Régions has taken a minority stake in the owner buyout of French clinical research business Axonal.
The group's founders and managers reinvested in the transaction. BNP and Crédit Agricole provided a debt package to finance the buyout.
FSI Régions invested via its €140m FCPR AED fund. The vehicle invests up to €4m per transaction and has so far made an average contribution of €1.4m across 48 deals.
The new capital structure will allow Axonal to pursue bolt-on opportunities in order to drive growth.
Company
Founded in 1989, Axonal provides project support to pharmaceutical companies, medical device manufacturers and not-for-profit sponsors in the management of clinical trials, pharmaco-epidemiological studies, surveys and observational studies.
The Nanterre-based business posted a €3.9m turnover and €90,000 EBITDA in 2010.
People
Cyril Chaumien and Serge Mesguich led the deal for FSI Régions. Denis Comet and Jean-Pierre Meunier are co-founders of Axonal.
Advisers
Equity – ACA François Mahe (Financial due diligence).
Management – 3S Finance (Corporate finance); Curtis (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater